Prostate cancer Board decisions

The Board restored the 100 percent rating for prostate cancer from August 1, 2022 to November 28, 2022 and denied a compensable rating for hypothyroidism. The effective date for TDIU was dismissed as moot.

The Board remands the claims for an initial compensable evaluation for erectile dysfunction and an increased initial evaluation for prostate cancer with proctectomy due to a duty to assist error regarding missing VA treatment records.

The Board denied earlier effective dates for service connection for Parkinson's disease, cerebral infarction, atrial fibrillation, prostate cancer, and obstructive sleep apnea.

The Board denied the Veteran's claim for service connection for prostate cancer, finding that there was no evidence of an in-service injury or event and that his prostate cancer did not have its onset during service.

The Board granted service connection for prostate cancer due to exposure to contaminated water at Camp Lejeune.

The Board denied the appeal for restoration of a 100% rating for prostate cancer and also denied special monthly compensation based on need for regular aid and attendance, but granted SMC based on housebound status from August 1, 2019.

The Veteran withdrew his appeal, and the Board dismissed all service connection claims.

The Board granted service connection for mucinous adenocarcinoma of the appendix and residuals of prostate cancer, resolving all reasonable doubt in favor of the Veteran.

The Board granted service connection for prostate cancer and remanded the claims for cardiovascular disease and hypertension for a new VA medical opinion.

The Board remands the claim for an earlier effective date for service connection of prostate cancer with voiding dysfunction due to a duty to assist error in not considering exposure to herbicide agents in Guam and failing to obtain an opinion on direct service connection.

The appeal of entitlement to service connection for prostate cancer was dismissed due to the untimely submission of a VA Form 10182.

The Board granted service connection for prostate cancer and erectile dysfunction, effective from July 9, 2007, based on the Veteran's exposure to environmental toxins during his active service in Southwest Asia.

The Veteran's erectile dysfunction was found to be aggravated by his service-connected prostate cancer, and an earlier effective date of July 3, 2017, for special monthly compensation based on loss of use of a creative organ is granted.

The Board remands the service connection claim for prostate cancer to obtain a medical opinion considering all potential exposures during the Veteran's service.

The Board denied the Veteran's claim for service connection for thyroid nodules, finding no evidence of a causal relationship between his condition and his military service. The claims for service connection for prostate cancer, asthma, and nose polyps were remanded for further development.

The Board granted service connection for prostate cancer, as it was related to the Veteran's exposure to contaminated water at Camp Lejeune.

The Board denied the Veteran's appeal for an earlier effective date for service connection and special monthly compensation, as no evidence supported a claim prior to June 27, 2011.

The Board denied the veteran's claims for an additional or higher level of special monthly compensation based on prostate cancer, a compensable rating for erectile dysfunction, and a compensable rating for the residuals of prostate cancer.

The Board granted restoration of a 100 percent disability rating for prostate cancer and the discontinuance of special monthly compensation for statutory housebound status, both deemed improper by the June 2024 rating decision.

The Board denied the Veteran's claim for service connection for prostate cancer, as it did not meet the necessary criteria.